FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
The January 31, 2026, conference in Mainz, Germany, will focus on advances in optic neuropathy diagnosis, artificial ...
Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...
Data estimates the prevalence of glaucoma currently is almost 50% higher than previously estimated and over 1.6 million ...
Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...
Management of geographic atrophy (GA) has changed with the introduction of retinal therapies aimed at slowing disease ...
Patient awareness of glaucoma differs markedly depending on urban and rural locations and the patient population, and that awareness or lack thereof impacts diagnosis, treatment, ...
A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results